Sign in

CIK 0000879407 · Large accelerated filer

ARROWHEAD PHARMACEUTICALS, INC.

Sign in to watch
Ticker
ARWR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Incorporated
DE
Entity type
operating
EIN
460408024
Phone
626-696-4702
Business address
177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
Former names
ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
  1. 4 Grant or award Chief Executive Officer acquired 800,000 shares (grant or award)
  2. 4 Gift Chief Executive Officer gave 1,126 shares (gift)
  3. 4 Gift Director gave 870 shares (gift)
  4. 4 Option exercise Chief Executive Officer acquired 40,510 shares (option exercise)
  5. 4 Open-market sale Director sold 9,575 shares at an average $79.32 ($759,443)
  6. 4 Open-market sale Director sold 3,000 shares at an average $71.26 ($213,780)
  7. 4 Open-market sale Chief Executive Officer sold 55,000 shares at an average $68.73 ($3,780,347)
  8. 4 Open-market sale Chief Scientific Officer sold 31,250 shares at an average $69.06 ($2,158,125)
  9. 10-K Report Annual Report
  10. 8-K Event Results of operations
  11. 4 Open-market sale Chief Medical Officer sold 19,500 shares at $69.39 ($1,353,105)
  12. 4 Open-market sale Chief Financial Officer sold 43,505 shares at an average $69.37 ($3,018,071)
  13. 3 Insider Initial Statement of Ownership
  14. 4 Open-market buy Director bought 1,000 shares at an average $50.47 ($50,465)
  15. 4 Open-market sale Chief Executive Officer sold 100,000 shares at an average $58.21 ($5,821,032)
  16. 4 Open-market sale Chief Financial Officer sold 29,166 shares at $54.04 ($1,576,131)
  17. 4 Open-market sale Director sold 10,000 shares at $48.00 ($480,000)
  18. 8-K Event Material agreement
  19. 3 Insider Initial Statement of Ownership
  20. 8-K Event Executive or director change

Page 22 of 69 · 1,363 filings